NEFL and early-onset autosomal dominant Alzheimer disease: Elevated Nf-L levels have been documented in a range of neurodegenerative and acute neurological conditions, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, traumatic brain injury, and stroke, where they reflect active axonal injury and correlate with disease severity and progression [16,21].